A recent study examined the associations between daily supplementation with 600 mg Ashwagandha root extract and psychological and physical performance outcomes in athletes engaged in team sports during pre-season training.
Study
Scientists conducted a randomised, double-blind, placebo-controlled trial over six weeks to evaluate the effect of 600 mg/day root-extracted Ashwagandha on salivary hormone concentrations, perceived recovery, and muscle strength in male and female semi-professional athletes during pre-season.
The study hypothesised that supplementation would be associated with favourable changes in salivary cortisol and cortisone concentrations, improved recovery perception, and enhanced muscle strength outcomes in team-sport settings.
A total of 56 athletes from a sports academy in Barcelona, Spain, who engaged in rugby, water polo, and football were recruited. All participants competed at a sub-elite level and were classified as healthy or free from disease. Participants were randomly assigned to Ashwagandha (ASH) or placebo (PLA) groups. ASH group participants received 600 mg/day of the KSM-66 Ashwagandha root extract standardised to greater than 5% withanolides, while those in the placebo group received 600 mg/day of chickpea flour encapsulated in hydroxypropyl methylcellulose.
At the first visit, participants received study information and provided self-reported height, mass, and career length data. Post-training salivary biomarkers, training-based muscle strength and aerobic capacity, and next-day recovery perception were assessed using the Hooper Index (HI). Data collection occurred at the academy gym, a familiar training ground for all participants.
Findings
Independent t-tests exhibited no significant baseline differences between ASH and PLA groups in age, height, body mass, or career length. Three participants discontinued due to scheduling conflicts unrelated to the intervention, resulting in 28 participants per group.
Only one ASH participant and one PLA participant reported mild headache and minor gastrointestinal discomfort, respectively. Cortisol increased significantly in PLA females from baseline to 42 days, but not in PLA males. Amylase showed an interaction effect in females, but post hoc tests were not significant. Testosterone, dehydroepiandrosterone sulfate (DHEA-S), and testosterone-to-cortisol ratio showed no significant changes in either sex.
ASH females showed significant improvements from baseline to 42 days in Overall HI scores, delayed-onset muscle soreness (DOMS), and fatigue scores, whereas males showed no significant changes in recovery perception. Both PLA and ASH males showed substantial improvements in pull-ups from baseline, consistent with training-related adaptations. ASH males also showed significant improvements in countermovement jump (CMJ) performance.
Conclusion
The current study suggests that 600 mg/day of Ashwagandha root extract for 42 days was associated with sex-specific outcomes in team-sport athletes during pre-season training. Females demonstrated improved recovery perception alongside stable cortisol concentrations, while males exhibited enhanced lower-body power and stable cortisone concentrations compared with placebo groups.
These findings should be interpreted in light of several limitations, including the sub-elite athlete sample, modest subgroup sizes, lack of dietary intake control, and environmental training conditions, which may limit generalisability. Nonetheless, the results support the potential role of Ashwagandha as a supportive adjunct to recovery that may help preserve hormonal stability and facilitate training adaptation during demanding pre-season periods.
Source:
https://www.news-medical.net/news/20260118/Ashwagandha-aids-recovery-without-blunting-training-stress-in-athletes.aspx